Decrease in adiponectin levels correlates to growth response in growth hormone-treated children

B Andersson1, L M S Carlsson, B Carlsson

  • 1Department of Pediatrics, Goteborg Pediatric Growth Research Center, The Institute of Clinical Sciences, Göteborg, Sweden.

Hormone Research
|March 5, 2009
PubMed

Insights

Growth hormone (GH) treatment in children lowers adiponectin levels, a hormone linked to obesity. This decrease in adiponectin correlates with improved growth response but not with insulin resistance.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Metabolic Research

Background:

  • Adiponectin, a hormone secreted by adipose tissue, is crucial in metabolic regulation.
  • Low adiponectin levels are associated with insulin resistance and obesity.
  • Growth hormone (GH) plays a vital role in childhood growth and metabolism.

Purpose of the Study:

  • To investigate the relationship between serum adiponectin levels and growth response during GH treatment in children.
  • To examine potential correlations between adiponectin changes, insulin levels, and insulin resistance in this cohort.

Main Methods:

  • A cohort of 94 short prepubertal children (75 boys, 19 girls) received daily GH injections.
  • Serum adiponectin levels were quantified using ELISA at baseline and at multiple time points post-treatment.
  • Statistical analyses, including correlation assessments, were performed to evaluate relationships between variables.

Main Results:

  • Serum adiponectin levels significantly decreased from baseline after 1 week, 3 months, and 1 year of GH treatment (p < 0.0001).
  • Baseline adiponectin showed a positive correlation with the first-year growth response (r = 0.26, p = 0.012).
  • The magnitude of adiponectin decrease after 3 months and 1 year significantly correlated with the first-year growth response (r = -0.38 and r = -0.47, respectively; p < 0.0001).

Conclusions:

  • Growth hormone treatment in prepubertal children leads to a significant reduction in serum adiponectin levels.
  • The observed decrease in adiponectin is positively correlated with the treatment-induced growth response.
  • No significant correlations were found between adiponectin levels and either insulin levels or insulin resistance (HOMA-IR) during GH therapy.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...